PyInvesting

Market research

CPH.AU Creso Pharma Limited

AU AUD Healthcare

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts
Market cap
23M
P/E ratio
Not available
Analyst target
Not available
Dividend yield
0.0%
Beta
2.62

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

Creso Pharma Limited is currently in a long term downtrend where the price is trading 14.0% below its 200 day moving average.

From a valuation standpoint, the stock is 88.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 30.3.

Creso Pharma Limited's total revenue sank by 63.5% to $994K since the same quarter in the previous year.

Its net income has dropped by 52.3% to $-13M since the same quarter in the previous year.

Finally, its free cash flow grew by 44.7% to $-3M since the same quarter in the previous year.

Based on the above factors, Creso Pharma Limited gets an overall score of 2/5.